Millipore Sigma Vibrant Logo

231085 Cilostamide - CAS 68550-75-4 - Calbiochem

Übersicht

Replacement Information

Key Spec Table

CAS #Empirical Formula
68550-75-4C₂₀H₂₆N₂O₃

Preis & Verfügbarkeit

Bestellnummer VerfügbarkeitVerpackung St./Pkg. Preis Menge
231085-10MG
Verfügbarkeit wird abgerufen...
Eingeschränkte Verfügbarkeit
Eingeschränkte Verfügbarkeit
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

      Kst.-Ampulle 10 mg
      Preis wird abgerufen...
      Preis nicht abrufbar
      Die Mindestmenge muss ein Vielfaches sein von
      Maximum Quantity is
      Bei Bestätigung Weitere Informationen
      Sie haben () gespart
       
      Bitte erfragen
      Description
      OverviewA cell-permeable selective inhibitor of cGMP-inhibited phosphodiesterase (PDE III; IC50 = 70 nM).
      Catalogue Number231085
      Brand Family Calbiochem®
      SynonymsN-Cyclohexyl-N-methyl-4-(1,2-dihydro-2-oxo-6-quinolyloxy)butyramide, OPC 3689
      References
      ReferencesVerghese, M.W., et al. 1995. J. Pharmacol. Exp. Ther. 272, 1313.
      Christensen, S.B., and Trophy, T.J. 1994. Ann. Rep. Med. Chem. 29, 185.
      Tang, K.M., et al. 1994. Eur. J. Pharmacol. 268, 105.
      Product Information
      CAS number68550-75-4
      ATP CompetitiveN
      FormWhite solid
      Hill FormulaC₂₀H₂₆N₂O₃
      Chemical formulaC₂₀H₂₆N₂O₃
      ReversibleN
      Structure formula ImageStructure formula Image
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetPDE 3
      Primary Target IC<sub>50</sub>70 nM against PDE III
      Purity≥98% by TLC
      Physicochemical Information
      Cell permeableY
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Standard Handling
      Storage +2°C to +8°C
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, refrigerate (4°C). Stock solutions are stable for up to 6 months at 4°C.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Bestellnummer GTIN
      231085-10MG 04055977217599

      Documentation

      Cilostamide - CAS 68550-75-4 - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      Cilostamide - CAS 68550-75-4 - Calbiochem Analysenzertifikate

      TitelChargennummer
      231085

      Literatur

      Übersicht
      Verghese, M.W., et al. 1995. J. Pharmacol. Exp. Ther. 272, 1313.
      Christensen, S.B., and Trophy, T.J. 1994. Ann. Rep. Med. Chem. 29, 185.
      Tang, K.M., et al. 1994. Eur. J. Pharmacol. 268, 105.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision05-June-2008 RFH
      SynonymsN-Cyclohexyl-N-methyl-4-(1,2-dihydro-2-oxo-6-quinolyloxy)butyramide, OPC 3689
      DescriptionA cell-permeable selective inhibitor of cGMP-inhibited phosphodiesterase (PDE III; IC50 = 70 nM).
      FormWhite solid
      CAS number68550-75-4
      Chemical formulaC₂₀H₂₆N₂O₃
      Structure formulaStructure formula
      Purity≥98% by TLC
      SolubilityDMSO (5 mg/ml)
      Storage +2°C to +8°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, refrigerate (4°C). Stock solutions are stable for up to 6 months at 4°C.
      Toxicity Standard Handling
      ReferencesVerghese, M.W., et al. 1995. J. Pharmacol. Exp. Ther. 272, 1313.
      Christensen, S.B., and Trophy, T.J. 1994. Ann. Rep. Med. Chem. 29, 185.
      Tang, K.M., et al. 1994. Eur. J. Pharmacol. 268, 105.